TransCode Therapeutics Inc. (NASDAQ:RNAZ) Stock Turns Volatile After The Recent Slump
TransCode Therapeutics Inc. (NASDAQ:RNAZ) jumped over 15% but was down 37% in the past month. The company has priced its
Read more
RNAZ
TransCode Therapeutics Inc (NASDAQ:RNAZ) Stock Continues to Fall: Down 36% in a Week
The RNA oncology firm TransCode Therapeutics Inc (NASDAQ:RNAZ) has not had a great time in recent days as far as
Read more
TransCode Therapeutics (NASDAQ:RNAZ) Sees Heavy Selling pressure: Where is The Bottom?
TransCode Therapeutics (NASDAQ:RNAZ) dropped 29% after the upcoming RNA oncology company priced its initial public offering (IPO) of 6.25 million
Read more